Suchergebnisse - "Korpanty, Grzegorz J"

PubPharm (9)

1

A Randomized Phase II Study of FOLFOX6/Bevacizumab With or Without Pelareorep in Patients With Metastatic Colorectal Cancer : IND.210, a Canadian Cancer Trials Group Trial

enthalten in: Clinical colorectal cancer | 2018

von Jonker, D. | Tang, P. | Kennecke, H. | +16

2

Canadian Cancer Trials Group (CCTG) IND211 : A randomized trial of pelareorep (Reolysin) in patients with previously treated advanced or metastatic non-small cell lung cancer receiving standard salvage therapy

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2018

von Bradbury, P. | Morris, D. | Nicholas, G. | +22

3

Lung cancer in never smokers from the Princess Margaret Cancer Centre

enthalten in: Oncotarget | 2018

von Korpanty, G. | Kamel-Reid, S. | Pintilie, M. | +9

4

Prognostic and predictive effects of TP53 co-mutation in patients with EGFR-mutated non-small cell lung cancer (NSCLC)

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2017

von Labbé, C. | Cabanero, M. | Korpanty, G. | +14

5

Treatment options for patients with brain metastases from EGFR/ALK-driven lung cancer

enthalten in: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology | 2017

von Doherty, M. | Korpanty, G. | Tomasini, P. | +14

6

Association of BRM promoter polymorphisms and esophageal adenocarcinoma outcome

enthalten in: Oncotarget | 2017

von Korpanty, G. | Eng, L. | Qiu, X. | +16

7

ALK-Rearranged Non-Small-Cell Lung Cancer Is Associated With a High Rate of Venous Thromboembolism

enthalten in: Clinical lung cancer | 2017

von Zer, A. | Moskovitz, M. | Hwang, D. | +13

CommentIn: Clin Lung Cancer. 2018 Jan;19(1):e71-e72. - PMID 28818428

8

Prognostic and predictive effects of TP53 co-mutation in patients with EGFR-mutated non-small cell lung cancer (NSCLC)

enthalten in: Lung cancer | 2017

von Labbé, C. | Cabanero, M. | Korpanty, G. | +14

9

Biomarkers That Currently Affect Clinical Practice in Lung Cancer : EGFR, ALK, MET, ROS-1, and KRAS

enthalten in: Frontiers in oncology | 2014

von Korpanty, G. | Graham, D. | Vincent, M. | +1

1
[1]